Cancer Immunology
Cancer Immunology refers to the relationship between immune function and cancer. The immunological mechanisms involved in cancer growth are highly complex and provide numerous potential points for intervention with small molecules, including extracellular enzymes, receptors and intracellular signal transduction pathways.
Cancer Immunology Products Targets
- STAT (10)
- PI 3-kinase (22)
- NTPDase (4)
- JAK (10)
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- Toll-like Receptor (11)
- TGF-β Receptor (9)
- STING-Dependent Signaling (1)
- Others (7)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- Purinergic (P2Y) Receptor (31)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
Products for Cancer Immunology
- Cat.No. Product Name Information/Activity
-
BCC4316
CGS 21680 HCl
CGS 21680 Hydrochloride is a selective adenosine A2A receptor agonist with a Ki of 27 nM.
-
BCC7163
CV 1808
53296-10-9
-
BCC6237
LUF 5834
333962-91-7
-
BCC7640
8-(3-Chlorostyryl)caffeine
147700-11-6
-
BCC7815
ANR 94
Adenosine A<sub>2A </sub>antagonist
-
BCC3798
Istradefylline (KW-6002)
Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson's disease.
-
BCC7977
Lu AA 47070
913842-25-8
-
BCC7372
SCH 442416
316173-57-6
-
BCC7306
SCH 58261
SCH 58261 is a potent, selective and competitive antagonist of adenosine A2A receptor with an IC50 of 15 nM, and displays 323-, 53- and 100-fold more selective for A2A receptor than A1, A2B, and A3 receptors, respectively.
-
BCC6165
TC-G 1004
1061747-72-5
